Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

Orthobiologics to 2016 - Alternatives to Surgery and Superior
Outcomes are Driving Wider Adoption of Orthobiologics
Published on March 2011

Report Summary

Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics

Summary

GBI Research's new report, 'Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of
Orthobiologics' provides key data, information and analysis on the Orthobiologics industry and analytical content on the market
dynamics. The report provides market landscape, competitive landscape and market trends information on Orthobiologics industry .
The report provides comprehensive information on the current practices and trends in the Orthobiologics industry. The report also
reviews the competitive landscape, and technology offerings. This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Market size and company share data for Orthobiologics.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009..
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the Orthobiologics market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the Orthobilogics market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next being thing in the Orthobilogics market' ' Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global Orthobilogics market and the factors
shaping it.

Table of Content

Table of Contents

1 Table of Contents

Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics (From Slideshare) Page 1/8


1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 GBI Research Guidance 9
3 Overview: Orthobiologics 10
3.1 Applications of Orthobiologics 10
4 Global Orthobiologics Devices : Market Characterization 12
4.1 Global Orthobiologics Devices Market, Revenue ($bn), 2002 ' 2009 12
4.2 Global Orthobiologics Devices Market, Revenue Forecast ($bn), 2009'2016 13
4.3 Global Orthobiologics Devices Market, Key Company Shares (%), 2009 14
4.4 Global Orthobiologics Devices Market, Dynamics 16
4.4.1 Market Drivers 16
4.4.2 Market Restraints 18
5 Global Orthobiologics Devices Market: Category Analysis and Forecasts 19
5.1 Global Bone Graft Substitutes Market, Revenue ($m), Historic, 2002 ' 2009 19
5.2 Global Bone Graft Substitutes Market, Revenue ($m), Forecast, 2009 ' 2016 20
5.2.1 Bone Graft Substitutes, Market Drivers 21
5.2.2 Bone Graft Substitutes, Market Restraint: Safety Concerns over Bone Morphogenetic Protein (BMP) in Spinal Fusion Surgeries
and High Cost is Slowing the Adoption 21
5.3 Global Viscosupplementation Market, Revenue ($m), Historic, 2002 ' 2009 22
5.4 Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 ' 2016 23
5.4.1 Viscosupplementation, Market Drivers 24
5.4.2 Viscosupplementation, Market Restraint: Pricing Challenges to Continue to Plague the Viscosupplementation Market 24
5.5 Global DBM Market, Revenue ($m), Historic, 2002 ' 2009 25
5.6 Global DBM Market, Revenue ($m), Forecast, 2009 ' 2016 26
5.6.1 DBM, Market Drivers 27
5.6.2 DBM, Market Restraint: Several Potential Disadvantages Such as the Potential to Transmit Human Immunodeficiency Virus May
Act as a Restraint on Market Growth 27
5.7 Global Bone Growth Stimulators Market, Revenues ($m), Historic, 2002 ' 2009 28
5.8 Global Bone Growth Stimulators Market, Revenues ($m), Forecast, 2009 ' 2016 29
5.8.1 Bone Growth Stimulators, Market Driver: Increasing Number of Fractures due to Ageing is Expected to Drive the Market Growth
for Bone Growth Stimulators 30
5.8.2 Bone Growth Stimulators, Market Restraint: Lack of Exact Knowledge about the Mechanism of Action for These Devices and
Lack of Studies in Specific Patient Groups will Restrict their Adoption 30
5.9 Global Bone Allografts Market, Revenue ($m), Historic, 2002-2009 31
5.10 Global Bone Allografts Market, Revenue ($m), Forecast, 2009-2016 32
6 Global Orthobiologics Devices Market: Country Analysis and Forecasts 33
6.1 Historic (2002'2009) and Forecast (2009-2016) Revenue, By Country 33
6.1.1 Orthobiologics Devices Market, US, Revenue ($bn), 2002 ' 2009 33
6.1.2 Orthobiologics Devices Market, Canada, Revenue ($m), 2002'2009 35
6.1.3 Orthobiologics Devices Market, Canada, Revenue ($m), 2009'2016 36
6.1.4 Orthobiologics Devices Market, UK, Revenue ($m), 2002'2009 37
6.1.5 Orthobiologics Devices Market, UK, Revenue ($m), 2009'2016 38
6.1.6 Orthobiologics Devices Market, Germany, Revenue ($m), 2002 ' 2009 39
6.1.7 Orthobiologics Devices Market, Germany, Revenue ($m), 2009'2016 40
6.1.8 Orthobiologics Devices Market, France, Revenue ($m), 2002'2009 41
6.1.9 Orthobiologics Devices Market, France, Revenue ($m), 2009'2016 42



6.1.10 Orthobiologics Devices Market, Italy, Revenue ($m), 2002'2009 43
6.1.11 Orthobiologics Devices Market, Italy, Revenue ($m), 2009'2016 44
6.1.12 Orthobiologics Devices Market, Spain, Revenue ($m), 2002'2009 45
6.1.13 Orthobiologics Devices Market, Spain, Revenue ($m), 2009'2016 46
6.1.14 Orthobiologics Devices Market, Brazil, Revenue ($m), 2002'2009 47
6.1.15 Orthobiologics Devices Market, Brazil, Revenue ($m), 2009'2016 48
6.1.16 Orthobiologics Devices Market, Japan, Revenue ($m), 2002'2009 49
6.1.17 Orthobiologics Devices Market, Japan, Revenue ($m), 2009'2016 50
6.1.18 Orthobiologics Devices Market, China, Revenue ($m), 2002'2009 51
6.1.19 Orthobiologics Devices Market, China, Revenue ($m), 2009'2016 52
6.1.20 Orthobiologics Devices Market, India, Revenue ($m), 2002'2009 53
6.1.21 Orthobiologics Devices Market, India, Revenue ($m), 2009'2016 54
6.1.22 Orthobiologics Devices Market, Australia, Revenue ($m), 2002'2009 55
6.1.23 Orthobiologics Devices Market, Australia, Revenue ($m), 2009'2016 56
7 Global Orthobiologics Devices Market: Competitive Assessment 57
7.1 Medtronic Inc. 57
7.1.1 Overview: 57
7.2 Genzyme Corporation 58
7.2.1 Overview 58
7.3 Depuy, Inc.(Johnson & Johnson) 58
7.3.1 Overview 58
7.4 Synthes, Inc. 59
7.4.1 Overview 59
7.5 Smith & Nephew Plc 60
7.5.1 Overview 60
7.6 Stryker 61
7.6.1 Overview 61
7.7 Orthofix International N.V 62
7.7.1 Overview 62
8 Global Orthobiologics Devices Market: Product Pipeline Analysis 63
8.1 Orthobiologics Market: Pipeline Products Summary 63
8.2 Profiles of Promising Products Under Clinical Development: 65
8.2.1 Synthetic Bone Graft Substitutes 65
8.2.2 BMP 67
8.2.3 Bone Growth Stimulators 68
8.2.4 Bone Allograft 70
8.2.5 Viscosupplementation 70
8.2.6 DBM 71
8.3 List of Pipeline Products 71
8.3.1 Pipeline Product Summary 71
9 Global Orthobiologics Devices Market: Consolidation Landscape 75
9.1 Key Deals 78
9.1.1 Medtronic to Acquire Osteotech 78
9.1.2 Landec Acquires Lifecore Biomedical 78
9.1.3 Baxter International Completes Acquisition Of ApaTech 79
9.1.4 TiGenix Completes Acquisition Of OrthoMimetics 79
9.1.5 NuVasive Invests In Progentix Orthobiology 79
9.1.6 Kinetic Concepts Acquires LifeCell 80



9.1.7 Pioneer Surgical Acquires Angstrom Medica 80
9.1.8 Pioneer Surgical Technology Acquires Encelle 80
9.1.9 Orthofix Acquires Blackstone Medical 80
10 Appendix 81
10.1 Definitions 81
10.1.1 Orthobiologics 81
10.2 Acronyms 81
10.3 Sources 82
10.4 Research Methodology 82
10.4.1 Secondary Research 82
10.4.2 Primary Research 82
10.4.3 Models 83
10.4.4 Forecasts 83
10.4.5 Expert Panels 83
10.5 Contact Us 83
10.6 Disclaimer 84

List of Tables

1.1 List of Tables
Table 1: Global Orthobiologics Devices Market, Revenue ($bn), 2002 - 2009 12
Table 2: Global Orthobiologics Devices Market, Revenue Forecast ($bn), 2009 - 2016 13
Table 3: Global Orthobiologics Devices Market, Key Company Share (Revenue $m), 2009 15
Table 4: Global Bone Graft Substitutes Market, Revenue ($m), Historic 2002 - 2009 19
Table 5: Global Bone Graft Substitutes Market, Revenue ($m), Forecast 2009 - 2016 20
Table 6: Global Viscosupplementation Market Revenue ($m), Historic, 2002 - 2009 22
Table 7: Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 - 2016 23
Table 8: Global DBM Market, Revenue ($m), Historic, 2002 - 2009 25
Table 9: Global DBM Market, Revenue ($m), Forecast, 2009 - 2016 26
Table 10: Global Bone Growth Stimulators Market, Revenue ($m), Historic , 2002 - 2009 28
Table 11: Global Bone Growth Stimulators Market, Revenues ($m), Forecast 2009 - 2016 29
Table 12: Global Bone Allografts Market, Revenue ($m), Historic, 2002 - 2009 31
Table 13: Global Bone Allografts Market, Revenue ($m), Forecast, 2009 - 2016 32
Table 14: Orthobiologics Market, US, Revenue ($m), 2002-2009 33
Table 15: Orthobiologics Market, US, Revenue ($m), 2009-2016 34
Table 16: Orthobiologics Market, Canada, Revenue ($m), 2002-2009 35
Table 17: Orthobiologics Market, Canada, Revenue ($m), 2009-2016 36
Table 18: Orthobiologics Market, UK, Revenue ($m), 2002-2009 37
Table 19: Orthobiologics Market, UK, Revenue ($m), 2009-2016 38
Table 20: Orthobiologics Market, Germany, Revenue ($m), 2002-2009 39
Table 21: Orthobiologics Market, Germany, Revenue ($m), 2009-2016 40
Table 22: Orthobiologics Market, France, Revenue ($m), 2002-2009 41
Table 23: Orthobiologics Market, France, Revenue ($m), 2009-2016 42
Table 24: Orthobiologics Market, Italy, Revenue ($m), 2002-2009 43
Table 25: Orthobiologics Market, Italy, Revenue ($m), 2009-2016 44
Table 26: Orthobiologics Market, Spain, Revenue ($m), 2002-2009 45
Table 27: Orthobiologics Market, Spain, Revenue ($m), 2009-2016 46
Table 28: Orthobiologics Market, Brazil, Revenue ($m), 2002-2009 47



Table 29: Orthobiologics Market, Brazil, Revenue ($m), 2009-2016 48
Table 30: Orthobiologics Market, Japan, Revenue ($m), 2002-2009 49
Table 31: Orthobiologics Market, Japan, Revenue ($m), 2009-2016 50
Table 32: Orthobiologics Market, China, Revenue ($m), 2002-2009 51
Table 33: Orthobiologics Market, China, Revenue ($m), 2009-2016 52
Table 34: Orthobiologics Market, India, Revenue ($m), 2002-2009 53
Table 35: Orthobiologics Market, India, Revenue ($m), 2009-2016 54
Table 36: Orthobiologics Market, Australia, Revenue ($m), 2002-2009 55
Table 37: Orthobiologics Market, Australia, Revenue ($m), 2009-2016 56
Table 38: Medtronic, Inc. , Marketed Products, 2010 57
Table 39: Genzyme Corporation, Marketed Products, 2010 58
Table 40: Depuy, Marketed Products, 2010 58
Table 41: Synthes, Inc, Marketed Products, 2010 59
Table 42: Smith & Nephew, Marketed Products, 2010 60
Table 43: Stryker, Marketed Products, 2010 61
Table 44: Orthofix International, Marketed Products, 2010 62
Table 45: Pipeline Products, Orthobiologics, by Development Stage, Global, 2010 63
Table 46: Pipeline Products, Orthobiologics, by Segment, Global, 2010 64
Table 47: To Evaluate The Safety And Effectiveness Of GEM OS1 Compared To Autologous Bone Graft As A Bone Regeneration
Device In Foot And Ankle Fusions 65
Table 48: The Efficacy Of rhBMP-2 For Posterolateral Lumbar Fusion In Smokers 67
Table 49: Orthobiologics, Pipeline Products, BMP, 2010 71
Table 50: Orthobiologics, Pipeline Products, Bone Allografts, 2010 72
Table 51: Orthobiologics, Pipeline Products, Bone Graft Substitutes, 2010 72
Table 52: Orthobiologics, Pipeline Products, Bone Growth Stimulators, 2010 73
Table 53: Orthobiologics, Pipeline Products, DBM, 2010 73
Table 54: Orthobiologics, Pipeline Products, Viscosupplementation, 2010 74
Table 55: Orthobiologics Market, Key Deals, 2006'2010* 76

List of Figures

1.2 List of Figures
Figure 1: Global Orthobiologics Devices Market, Revenue ($bn), 2002 - 2009 12
Figure 2: Global Orthobiologics Devices Market, Revenue Forecast ($bn), 2009 - 2016 13
Figure 3: Global Orthobiologics Devices Market, Key Company Shares (%), 2009 14
Figure 4: Global Bone Graft Substitutes Market, Revenue ($m), Historic 2002 - 2009 19
Figure 5: Global Bone Graft Substitutes Market, Revenue ($m), Forecast 2009 - 2016 20
Figure 6: Global Viscosupplementation Market Revenue ($m), Historic, 2002 - 2009 22
Figure 7: Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 - 2016 23
Figure 8: Global DBM Market, Revenue ($m), Historic, 2002 - 2009 25
Figure 9: Global DBM Market, Revenue ($m), Forecast, 2009 - 2016 26
Figure 10: Global Bone Growth Stimulators Market, Revenue ($m), Historic , 2002 - 2009 28
Figure 11: Global Bone Growth Stimulators Market, Revenues ($m), Forecast 2009 - 2016 29
Figure 12: Global Bone Allografts Market, Revenue ($m), Historic, 2002 - 2009 31
Figure 13: Global Bone Allografts Market, Revenue ($m), Forecast, 2009 - 2016 32
Figure 15: Orthobiologics Market, US, Revenue ($m), 2002-2009 33
Figure 16: Orthobiologics Market, US, Revenue ($m), 2009-2016 34
Figure 17: Orthobiologics Market, Canada, Revenue ($m), 2002-2009 35



Figure 18: Orthobiologics Market, Canada, Revenue ($m), 2009-2016 36
Figure 19: Orthobiologics Market, UK, Revenue ($m), 2002-2009 37
Figure 20: Orthobiologics Market, UK, Revenue ($m), 2009-2016 38
Figure 21: Orthobiologics Market, Germany, Revenue ($m), 2002-2009 39
Figure 22: Orthobiologics Market, Germany, Revenue ($m), 2009-2016 40
Figure 23: Orthobiologics Market, France, Revenue ($m), 2002-2009 41
Figure 24: Orthobiologics Market, France, Revenue ($m), 2009-2016 42
Figure 25: Orthobiologics Market, Italy, Revenue ($m), 2002-2009 43
Figure 26: Orthobiologics Market, Italy, Revenue ($m), 2009-2016 44
Figure 27: Orthobiologics Market, Spain, Revenue ($m), 2002-2009 45
Figure 28: Orthobiologics Market, Spain, Revenue ($m), 2009-2016 46
Figure 29: Orthobiologics Market, Brazil, Revenue ($m), 2002-2009 47
Figure 30: Orthobiologics Market, Brazil, Revenue ($m), 2009-2016 48
Figure 31: Orthobiologics Market, Japan, Revenue ($m), 2002-2009 49
Figure 32: Orthobiologics Market, Japan, Revenue ($m), 2009-2016 50
Figure 33: Orthobiologics Market, China, Revenue ($m), 2002-2009 51
Figure 34: Orthobiologics Market, China, Revenue ($m), 2009-2016 52
Figure 35: Orthobiologics Market, India, Revenue ($m), 2002-2009 53
Figure 36: Orthobiologics Market, India, Revenue ($m), 2009-2016 54
Figure 37: Orthobiologics Market, Australia, Revenue ($m), 2002-2009 55
Figure 38: Orthobiologics Market, Australia, Revenue ($m), 2009-2016 56
Figure 39: Medtronic, Inc. , Pipeline Products, 2010 57
Figure 40: Depuy, Pipeline Products, 2010 59
Figure 41: Smith & Nephew , Pipeline Products, 2010 60
Figure 42: Stryker , Pipeline Products, 2010 61
Figure 43: Orthofix International , Pipeline Products, 2010 62
Figure 44: Pipeline Products, Orthobiologics, by Development Stage, Global, 2010 63
Figure 45: Pipeline Products, Orthobiologics, by Segment, Global, 2010 64
Figure 46: Orthobiologics Market Deal Analysis, Value ($m) and Volume, 2006'2010 75


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.

Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiol
ogics

Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 3 500.00 Quantity: _____

Site License--USD 7 000.00 Quantity: _____

Corporate License--USD 10 500.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics

Recommended

Recommended

More Related Content

More from ReportLinker.com

More from ReportLinker.com (20)

Orthobiologics to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics